Dr. Ted Kolodka joined DiaMedica in 2011 after 9 years as the Intellectual Property Manager at Cangene Corporation, a biopharmaceutical company that develops, manufactures and markets specialty plasma products and recombinant therapeutic proteins. He brings proven business development skills from the biopharmaceutical industry including: intellectual property management, technology development, product commercialization and management of products from pre-clinical research through regulatory approval. Dr. Kolodka earned his PhD at the Howard Hughes Medical Institute (HHMI), Baylor College of Medicine in Houston, Texas and completed a post-doctoral fellowship at SUNY, Stony Brook, New York. Dr. Kolodka also studied patent law at Orange & Chari, a patent firm with McCarthy Tétrault (Toronto).